<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="33313">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01711619</url>
  </required_header>
  <id_info>
    <org_study_id>1.02.7007</org_study_id>
    <nct_id>NCT01711619</nct_id>
  </id_info>
  <brief_title>SubQStim: A Post-market Study of Subcutaneous Nerve Stimulation in Failed Back Surgery Syndrome (FBSS) Patients</brief_title>
  <official_title>Interventional, Prospective, Multicenter, Randomized, Parallel-arm Study to Compare the Effectiveness of Peripheral Nerve Stimulation (PNS) Utilizing a Subcutaneous Lead Implant Technique (SQS) Plus Optimized Medical Management (OMM) Versus OMM Alone in Patients Suffering From Back Pain Due to Failed Back Surgery Syndrome (FBSS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic International Trading Sarl</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic International Trading Sarl</source>
  <oversight_info>
    <authority>Austria: Austrian Medicines and Medical Devices Agency</authority>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the effectiveness of peripheral nerve stimulation
      utilizing a subcutaneous lead implant technique (SQS) plus optimized medical management
      (OMM) versus OMM alone in patients suffering from back pain due to Failed Back Surgery
      Syndrome (FBSS).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Anticipated">November 2020</completion_date>
  <primary_completion_date type="Anticipated">November 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Effectiveness of treatment on reduction of back pain intensity.</measure>
    <time_frame>9 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>VAS scales will be used to determine the effectiveness of treatments on the reduction of back pain intensity.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Greater Average Change in Back Pain</measure>
    <time_frame>6 and 9 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>VAS scales will be used to determine the effectiveness of treatments on the average change of back pain intensity.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Failed Back Surgery Syndrome</condition>
  <arm_group>
    <arm_group_label>SQS plus OMM</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>OMM</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>subcutaneous nerve stimulation</intervention_name>
    <description>subcutaneous nerve stimulation plus optimized medical management</description>
    <arm_group_label>SQS plus OMM</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Optimized Medical Management</intervention_name>
    <description>Optimized medical management</description>
    <arm_group_label>OMM</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subject has signed and dated the Patient Informed Consent /Patient Information Sheet
             prior to any study-related activities being conducted

          2. Subject is ≥ 18 years of age at time of informed consent

          3. Subject is willing and available to attend visits as scheduled and to comply with the
             study protocol

          4. Subject is willing and able to undergo assessments as part of the evaluation for
             eligibility and endpoints

          5. Subject is willing and able to use the external neurostimulator, recharging equipment
             (if applicable), and patient programmer per the schedule required by the protocol

          6. Subject has been diagnosed with FBSS (i.e.):

               -  Has had persistent pain for 6 months following most recent anatomically correct,
                  successful surgery AND

               -  There are no further therapeutic surgical options available as assessed by
                  appropriate investigation

          7. Based on the opinion of the Principal Investigator, subject's back pain is considered
             intractable and has been adequately treated, as defined by:

               -  Subject has failed an appropriate trial of at least 3 different classes of back
                  pain treatments (pharmaceutical and/or non-pharmaceutical)

          8. Based on the opinion of the implanting physician, subject is an appropriate implant
             candidate for the SQS system

        Exclusion Criteria:

          1. Subject has been or is currently being treated with spinal cord stimulation,
             subcutaneous nerve stimulation, peripheral nerve stimulation or an implantable
             intrathecal drug delivery system

          2. Subject has evidence of an active disruptive psychiatric disorder that is significant
             enough to impact the perception of pain, compliance to intervention and/or ability to
             evaluate treatment outcome, as determined by the investigator

          3. Subject has a pain condition unrelated to FBSS that is severe enough to overshadow
             the FBSS pain in the opinion of the investigator

          4. Subject has evidence of a spinal instability or anatomic compression that requires
             further surgery

          5. Subject has had spinal fusion at more than 3 vertebral levels

          6. Subject is currently enrolled in or plans to enroll in any concurrent drug and/or
             device study that may confound the results of this study

          7. Subject is allergic or has shown hypersensitivity to any materials of the device
             system which come in contact with the body

          8. Subject has a history of coagulation disorder or lupus erythematosus

          9. Subject is involved in current litigation regarding back pain
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sam Eldabe, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The James Cook Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kristi Winterfeldt, MSHS</last_name>
    <phone>41218038208</phone>
    <email>kristi.l.winterfeldt@medtronic.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hunter Pain Clinic</name>
      <address>
        <city>Broadmeadow</city>
        <zip>2292</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc Russo, MD</last_name>
      <phone>61249851860</phone>
    </contact>
    <investigator>
      <last_name>Marc Russo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Greenslopes Private Hospital</name>
      <address>
        <city>Greenslopes</city>
        <zip>4120</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James O'Callaghan, MD</last_name>
      <phone>617339547100</phone>
    </contact>
    <investigator>
      <last_name>James O'Callaghan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal North Shore Hospital</name>
      <address>
        <city>St. Leonards</city>
        <zip>2065</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charles Brooker, MD</last_name>
      <phone>6194631500</phone>
    </contact>
    <investigator>
      <last_name>Charles Brooker, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Metro Spinal Clinic</name>
      <address>
        <city>Victoria</city>
        <zip>3162</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bruce Mitchell, MD</last_name>
      <phone>061395956111</phone>
    </contact>
    <investigator>
      <last_name>Bruce Mitchell, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Krankenhaus der Elisabethinen</name>
      <address>
        <city>Graz</city>
        <zip>8020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Kern, MD</last_name>
      <phone>4331670633190</phone>
    </contact>
    <investigator>
      <last_name>Michael Kern, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Krankenhaus der Landes Kärnten</name>
      <address>
        <city>Klagenfurt am Wörthersee</city>
        <zip>9020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rudolf Likar, MD</last_name>
      <phone>4346353826120</phone>
    </contact>
    <investigator>
      <last_name>Rudolf Likar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Krankenhaus der Barmherzigen Brüder</name>
      <address>
        <city>Vienna</city>
        <zip>1021</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Astrid Chiari, MD</last_name>
      <phone>43211215040</phone>
    </contact>
    <investigator>
      <last_name>Astrid Chiari, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ZNA Middelheim</name>
      <address>
        <city>Antwerp</city>
        <zip>2020</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Hes, MD</last_name>
      <phone>32477286244</phone>
    </contact>
    <investigator>
      <last_name>Robert Hes, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sint Jan</name>
      <address>
        <city>Brugge</city>
        <zip>8000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ann Ver Donck, MD</last_name>
      <phone>3250452586</phone>
    </contact>
    <investigator>
      <last_name>Ann Ver Donck, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>INDC Jolimont</name>
      <address>
        <city>La Louviere</city>
        <zip>7100</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Herbert Rooijakkers, MD</last_name>
      <phone>32475924051</phone>
    </contact>
    <investigator>
      <last_name>Herbert Rooijakkers, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pijnkliniek Stedelijk Ziekenhuis</name>
      <address>
        <city>Roselare</city>
        <zip>8800</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kris Verbeek</last_name>
      <phone>3251236555</phone>
    </contact>
    <investigator>
      <last_name>Olivier De Coster, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospices civils de LYON</name>
      <address>
        <city>Lyon</city>
        <zip>69003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrick Mertens, MD</last_name>
      <phone>33472118903</phone>
    </contact>
    <investigator>
      <last_name>Patrick Mertens, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique Brétéché</name>
      <address>
        <city>Nantes</city>
        <zip>44046</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bénédicte Bouche, MD</last_name>
      <phone>33251867844</phone>
    </contact>
    <investigator>
      <last_name>Bénédicte Bouche, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fondation Rothschild</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean-Baptiste Thiebaut, MD</last_name>
      <phone>33148036909</phone>
    </contact>
    <investigator>
      <last_name>Jean-Baptiste Thiebaut, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Märkische Kliniken GmbH / Marienhospital Letmathe</name>
      <address>
        <city>Iserlohn-Letmathe</city>
        <zip>58642</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wolfgang Welke, MD</last_name>
      <phone>492088376304</phone>
    </contact>
    <investigator>
      <last_name>Wolfgang Welke, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Jena</name>
      <address>
        <city>Jena</city>
        <zip>07743</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Walter, MD</last_name>
      <phone>4936419323080</phone>
    </contact>
    <investigator>
      <last_name>Rupert Reichart, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jan Walter, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Köln</name>
      <address>
        <city>Köln</city>
        <zip>50937</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Athanasios Koulousakis, MD</last_name>
      <phone>492214784483</phone>
    </contact>
    <investigator>
      <last_name>Athanasios Koulousakis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tel Aviv Medical Center</name>
      <address>
        <city>Tel Aviv</city>
        <zip>61999</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anat Yafe, PhD</last_name>
      <phone>97236974581</phone>
    </contact>
    <investigator>
      <last_name>Silviu Brill, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Albert Schweitzer Ziekenhuis</name>
      <address>
        <city>Dordrecht</city>
        <zip>3300</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ismail Gültuna, MD</last_name>
      <phone>31184434219</phone>
    </contact>
    <investigator>
      <last_name>Ismail Gültuna, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Amphia Ziekenhuis</name>
      <address>
        <city>Oosterhout-Breda</city>
        <zip>3079</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Henk Van Driel, MD</last_name>
      <phone>31162327065</phone>
    </contact>
    <investigator>
      <last_name>Henk Van Driel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Maasstad Ziekenhuis</name>
      <address>
        <city>Rotterdam</city>
        <zip>3079</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Renate Munnikes, MD</last_name>
      <phone>31102912285</phone>
    </contact>
    <investigator>
      <last_name>Renate Munnikes, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario del Rio Hortega</name>
      <address>
        <city>Valladolid</city>
        <zip>47012</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Enrique Ortega, MD</last_name>
      <phone>34983420400</phone>
    </contact>
    <investigator>
      <last_name>Enrique Ortega, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital de Morges</name>
      <address>
        <city>Morges</city>
        <zip>1110</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne Durrer</last_name>
      <phone>41218042828</phone>
    </contact>
    <investigator>
      <last_name>Eric Buchser, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The James Cook Hospital</name>
      <address>
        <city>Middlesbrough</city>
        <zip>TS4 3BW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Sam Eldabe, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Austria</country>
    <country>Belgium</country>
    <country>France</country>
    <country>Germany</country>
    <country>Israel</country>
    <country>Netherlands</country>
    <country>Spain</country>
    <country>Switzerland</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 1, 2014</lastchanged_date>
  <firstreceived_date>July 12, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Failed Back Surgery Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
